Do Non-Glycaemic Markers Add Value to Plasma Glucose and Hemoglobin A1c in Predicting Diabetes? Yuport Health Checkup Center Study

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Kashima, Saori ^a   Inoue, Kazuo ^b   Matsumoto, Masatoshi ^c   Akimoto, Kimihiko ^d  

^a HIROSHIMA UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^d Akimoto Occupational Health Consultant Office   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; LIPID; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; DISEASE MARKER; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEALTH CENTER; HEMOGLOBIN BLOOD LEVEL; HUMAN; JAPANESE; LEUKOCYTE COUNT; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84879255719     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066899     Document Type: Article

References (46)

1. Dinneen SF, Maldonado D 3rd, Leibson CL, Klee GG, Li H, et al (1998) Effects of changing diagnostic criteria on the risk of developing diabetes. Diabetes Care 21: 1408-1413.
2. Chou P, Li CL, Wu GS, Tsai ST, (1998) Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes. Diabetes Care 21: 1183-1187.
3. Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett Connor EL, et al. (1997) Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46: 701-710.
4. Nagi DK, Knowler WC, Charles MA, Liu QZ, Hanson RL, et al. (1995) Early and late insulin response as predictors of NIDDM in Pima Indians with impaired glucose tolerance. Diabetologia 38: 187-192.
5. Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, et al. (2006) Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 29: 1619-1625.
6. Inoue K, Matsumoto M, Akimoto K, (2008) Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes. Diabetic Medicine 25: 1157-1163.
7. Heianza Y, Hara S, Arase Y, Saito K, Fujiwara K, et al. (2011) HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. The Lancet 378: 147-155.
8. Dotevall A, Johansson S, Wilhelmsen L, Rosengren A, (2004) Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study. Diabet Med 21: 615-622.
9. Wannamethee SG, Shaper AG, Lennon L, Whincup PH, (2005) Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 28: 2913-2918.
10. Sattar N, Scherbakova O, Ford I, O'Reilly DSJ, Stanley A, et al. (2004) Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes 53: 2855-2860.
11. Sato KK, Hayashi T, Nakamura Y, Harita N, Yoneda T, et al. (2008) Liver enzymes compared with alcohol consumption in predicting the risk of type 2 diabetes: the Kansai Healthcare Study. Diabetes Care 31: 1230-1236.
12. Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, et al. (2005) Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care 28: 1757-1762.
13. Monami M, Bardini G, Lamanna C, Pala L, Cresci B, et al. (2008) Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. Metabolism 57: 387-392.
14. Ford ES, Schulze MB, Bergmann MM, Thamer C, Joost HG, et al. (2008) Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes Care 31: 1138-1143.
15. Doi Y, Kubo M, Yonemoto K, Ninomiya T, Iwase M, et al. (2007) Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study. Obesity (Silver Spring) 15: 1841-1850.
16. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, et al. (2002) High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51: 455-461.
17. Nakanishi N, Yoshida H, Matsuo Y, Suzuki K, Tatara K, (2002) White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men. Diabetologia 45: 42-48.
18. Tan KC, Wat NM, Tam SC, Janus ED, Lam TH, et al. (2003) C-reactive protein predicts the deterioration of glycemia in Chinese subjects with impaired glucose tolerance. Diabetes Care 26: 2323-2328.
19. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM, (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286: 327-334.
20. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, et al. (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51: 1596-1600.
21. Dehghan A, van Hoek M, Sijbrands EJG, Hofman A, Witteman JCM, (2008) High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 31: 361-362.
22. Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, et al. (2009) Association between serum uric acid and development of type 2 diabetes. Diabetes Care 32: 1737-1742.
23. Onat A, Hergenc G, Sari I, Karabulut A, Can G, (2007) Elevated LDL-cholesterol level predicts diabetes in centrally obese women but not men: relative roles of insulin resistance and central obesity. Circ J 71: 1463-1467.
24. Garrido-Sanchez L, Cardona F, Garcia-Fuentes E, Rojo-Martinez G, Gomez-Zumaquero JM, et al. (2008) Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus. Eur J Clin Invest 38: 615-621.
25. Wilson PW, D'Agostino RB, Fox CS, Sullivan LM, Meigs JB, (2011) Type 2 diabetes risk in persons with dysglycemia: the Framingham Offspring Study. Diabetes Res Clin Pract 92: 124-127.
26. Harita N, Hayashi T, Sato KK, Nakamura Y, Yoneda T, et al. (2009) Lower serum creatinine is a new risk factor of type 2 diabetes. Diabetes Care 32: 424-426.
27. Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K, (2007) Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 29: 115-128.
28. Kodama S, Horikawa C, Fujihara K, Heianza Y, Hirasawa R, et al. (2012) Comparisons of the strength of associations with future type 2 diabetes risk among anthropometric obesity indicators, including waist-to-height ratio: A meta-analysis. Am J Epidemiol 176: 959-969.
29. Hu FB, Sigal RJ, Rich-Edwards JW, Colditz GA, Solomon CG, et al. (1999) Walking compared with vigorous physical activity and risk of type 2 diabetes in women: A Prospective Study. JAMA 282: 1433-1439.
30. Sairenchi T, Iso H, Nishimura A, Hosoda T, Irie F, et al. (2004) Cigarette smoking and risk of type 2 diabetes mellitus among middle-aged and elderly Japanese men and women. American Journal of Epidemiology 160: 158-162.
31. Wang W, Lee ET, Howard BV, Fabsitz RR, Devereux RB, et al. (2011) Fasting plasma glucose and hemoglobin A1c in identifying and predicting diabetes: the strong heart study. Diabetes Care 34: 363-368.
32. Sattar N, (2012) Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities. Diabet Med 29: 5-13.
33. Inoue K, Inoue M, Matsumoto M, Akimoto K, (2012) Persistent fasting hyperglycaemia more predictive of Type 2 diabetes than is transient hyperglycaemia. Diabet Med 29: 1327-1334.
34. Inoue K, Matsumoto M, Akimoto K, (2009) The threshold for definition of impaired fasting glucose in a Japanese population. Diabet Med 26: 1175-1178.
35. International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32: 1327-1334.
36. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, et al. (2010) Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetology International 1: 2-20.
37. Friedewald WT, Levy RI, Fredrickson DS, (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
38. DeLong ER, DeLong DM, Clarke-Pearson DL, (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
39. Youden WJ, (1950) Index for rating diagnostic tests. Cancer 3: 32-35.
40. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB, (2005) Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 81: 555-563.
41. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Despres JP, (1993) Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr 58: 463-467.
42. Waki K, Noda M, Sasaki S, Matsumura Y, Takahashi Y, et al. (2005) Alcohol consumption and other risk factors for self-reported diabetes among middle-aged Japanese: a population-based prospective study in the JPHC study cohort I. Diabetic Medicine. 22: 323-331.
43. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 1183-1197.
44. The committee of Japan Diabetes Society on the classification and diagnostic criteria of diabetes mellitus (1999) [Report of the Committee of Japan Diabetes Society on the Classification and Diagnostic Criteria of Diabetes Mellitus]. Journal of the Japan Diabetes Society 42: 385-404.
45. Liu E, Meigs JB, Pittas AG, Economos CD, McKeown NM, et al. (2010) Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. Am J Clin Nutr 91: 1627-1633.
46. Dallmeier D, Larson MG, Wang N, Fontes JD, Benjamin EJ, et al. (2012) Addition of inflammatory biomarkers did not improve diabetes prediction in the community: the Framingham heart study. J Am Heart Assoc. 1: e000869. Available: http://jaha.ahajournals.org/content/1/4/e000869.abstract. Accessed Aug 1, 2013.